Citation 38194

SCHOLS,D: WUTZLER,P: KLOCKING,R: HELBIG,B: DE CLERCQ,E:. (1991). SELECTIVE INHIBITORY ACTIVITY OF POLYHYDROXYCARBOXYLATES DERIVED FROM PHENOLIC COMPOUNDS AGAINST HUMAN IMMUNODEFICIENCY VIRUS REPLICATION.. 4(7)

Citation Details

Title	SELECTIVE INHIBITORY ACTIVITY OF POLYHYDROXYCARBOXYLATES DERIVED FROM PHENOLIC COMPOUNDS AGAINST HUMAN IMMUNODEFICIENCY VIRUS REPLICATION.
Authors	SCHOLS,D: WUTZLER,P: KLOCKING,R: HELBIG,B: DE CLERCQ,E:
Year	1991
Volume	4
Issue	7

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (13)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAFFEIC ACID	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAFFEIC ACID	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GENTISINIC ACID	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	GENTISINIC ACID	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	GENTISINIC ACID	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISINIC ACID	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISINIC ACID	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENTISINIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID,HYDRO:	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CAFFEIC ACID,HYDRO:	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CAFFEIC ACID,HYDRO:	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID,HYDRO:	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID,HYDRO:	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID,HYDRO:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PYROGALLOL	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PYROGALLOL	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PYROGALLOL	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PYROGALLOL	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PYROGALLOL	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PYROGALLOL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CATECHOL	INACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CATECHOL	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CATECHOL	INACTIVE
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHOL	WEAK ACTIVITY
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHOL	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHOL	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHLOROGENIC ACID	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CHLOROGENIC ACID	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHLOROGENIC ACID	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROGENIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PROTOCATECHUIC ACID	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PROTOCATECHUIC ACID	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PROTOCATECHUIC ACID	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOCATECHUIC ACID	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOCATECHUIC ACID	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTOCATECHUIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOLUENE,2-3-DIHYDROXY:	WEAK ACTIVITY
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOLUENE,2-3-DIHYDROXY:	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TOLUENE,2-3-DIHYDROXY:	WEAK ACTIVITY
4	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOLUENE,2-3-DIHYDROXY:	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOLUENE,2-3-DIHYDROXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOLUENE,2-5-DIHYDROXY:	WEAK ACTIVITY
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOLUENE,2-5-DIHYDROXY:	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TOLUENE,2-5-DIHYDROXY:	INACTIVE
4	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOLUENE,2-5-DIHYDROXY:	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOLUENE,2-5-DIHYDROXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOLUENE,3-4-DIHYDROXY:	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	TOLUENE,3-4-DIHYDROXY:	WEAK ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TOLUENE,3-4-DIHYDROXY:	WEAK ACTIVITY
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOLUENE,3-4-DIHYDROXY:	WEAK ACTIVITY
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOLUENE,3-4-DIHYDROXY:	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOLUENE,3-4-DIHYDROXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PHENYLACETIC ACID,2-5-DIHYDROXY:	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PHENYLACETIC ACID,2-5-DIHYDROXY:	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHENYLACETIC ACID,2-5-DIHYDROXY:	INACTIVE
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYLACETIC ACID,2-5-DIHYDROXY:	WEAK ACTIVITY
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYLACETIC ACID,2-5-DIHYDROXY:	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYLACETIC ACID,2-5-DIHYDROXY:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PHENYLACETIC ACID,3-4-DIHYDROXY:	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	PHENYLACETIC ACID,3-4-DIHYDROXY:	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PHENYLACETIC ACID,3-4-DIHYDROXY:	INACTIVE
4	VIRAL ADSORPTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYLACETIC ACID,3-4-DIHYDROXY:	ACTIVE
5	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYLACETIC ACID,3-4-DIHYDROXY:	ACTIVE
6	GIANT CELL FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENYLACETIC ACID,3-4-DIHYDROXY:	ACTIVE

Show SPARQL Queries (1)